Clinical trial Recruiting at 1 site Interventional Ages 18 and up

Using autofluorescence imaging during surgery for primary hyperparathyroidism

Official title: Use of Intraoperative Autofluorescence Imaging in Surgery for Primary Hyperparathyroidism - a Randomized Controlled Trial.

Run by Aarhus University Hospital · NCT06230380 · Data updated 2026-11-12

This study tests if using special imaging during surgery can help doctors find and remove the right parathyroid glands in patients with primary hyperparathyroidism.

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment100 (estimated)
SponsorAarhus University Hospital
Academic / other
Locations1 site (Aarhus)
StatusRecruiting
StartedJanuary 1, 2024
Main results expectedJanuary 2026
Study endsJune 1, 2026
Registry record updatedJanuary 29, 2025
Trial IDNCT06230380 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adults over 18 years old diagnosed with primary hyperparathyroidism who require exploratory parathyroidectomy.

Probably not a fit

Patients with concordant high-confidence imaging or those who have had previous thyroid or parathyroid surgeries may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study evaluates the effectiveness of autofluorescence imaging as a surgical aid during parathyroidectomy for patients with primary hyperparathyroidism. The goal is to improve the identification of both normal and pathological parathyroid glands, which can be challenging during surgery. By utilizing this imaging technique, surgeons may enhance their ability to localize and remove the affected glands, potentially reducing the risk of persistent disease. The study involves patients who are scheduled for exploratory parathyroid surgery and will measure intraoperative parathyroid hormone levels.

Why it matters

Potential benefit: If successful, this approach could lead to more effective surgeries and better outcomes for patients with primary hyperparathyroidism.

How similar studies have gone: While the use of autofluorescence imaging in surgery is gaining interest, this specific application in primary hyperparathyroidism is relatively novel and has not been extensively tested in prior studies.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Age\>18 years and able to give informed consent.
* A diagnosis of PHPT.
* Planned exploratory PTX with ioPTH measurement.

Exclusion Criteria:

* Concordant high-confidence imaging; planned focused/selective PTX
* Previous thyroid or parathyroid surgery.
* Planned simultaneous thyroid surgery.
* MEN, lithium induced hyperparathyroidism.
* eGFR \< 30.
* Kidney transplant.

Where it's running

  • Aarhus University Hospital
    Aarhus, Denmark
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.